Nanjing, China

Jianrui Zhu

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Legend Biotech USA Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jianrui Zhu. Retrieved from https://idiyas.com/inventor/jianrui-zhu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jianrui Zhu: Innovator in Biotech

Introduction

Jianrui Zhu is a prominent inventor based in Nanjing, China. He has made significant contributions to the field of biotechnology, particularly in the development of binding molecules. His work has implications for various therapeutic applications.

Latest Patents

Jianrui Zhu holds a patent for "CD20 Binding Molecules and Uses Thereof." This patent showcases his innovative approach to targeting specific proteins, which can be crucial in the treatment of certain diseases.

Career Highlights

Currently, Jianrui Zhu is employed at Legend Biotech USA Inc. His role at the company allows him to further his research and development efforts in the biotech sector. With a focus on advancing medical treatments, he continues to push the boundaries of innovation.

Collaborations

Jianrui Zhu collaborates with notable colleagues, including Xiaohu Fan and Zhe Zhou. Their combined expertise enhances the research and development initiatives at Legend Biotech USA Inc.

Conclusion

Jianrui Zhu is a key figure in the biotechnology field, with a patent portfolio that reflects his innovative spirit. His contributions are paving the way for advancements in medical treatments and therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…